Updated on 22 November 2016
Harvinder Singh, Board of Directors, APACMed and Divisional Vice President, Abbott Vascular, Asia Pacific and Japan
What have been the achievements of APACMed in the past one year?
APACMed has entered its second year and has been getting good response and reception from the industry and regional associations like Australia's MTTA of which we are one of the board members. India has also come up with its own version of medical technology industry association. So in terms of the bringing the industry together we are getting lot of tractions. This is the first time that other than the old associations, a new association is getting attention of government bodies, regulators and different stake holders. It has been a good year in terms of accomplishments that we have achieved in building a base in the industry.
What role is APACMed playing in bridging the medtech industry with regulatory bodies in Asia?
This industry is coming up with products and innovations that physicians do not get to see in medical college or during their training. So this is the industry's task to train the physicians on such innovations. Similarly, the industry has a strong role to work with the regulators in making them understand that how a certain innovation or a device can bring change in the healthcare system. What we can do together is speeding up the approval process and establishing one voice on behalf of the industry to communicate with the regulators. This would be extremely constructive in dealing with regulators of different countries where one can approach as an industry rather than an individual company. You can impress upon the regulators and get an understanding from their side on different standards that need to be achieved to get approval for a device. This would also help the industry to meet those standards with transparency and better understanding. Approaching the regulators as an industry also helps in building trust with the authority and credibility and simplifying the whole process.
Is the association equally influential in communicating with countries that are still in the process of building a robust regulatory structure?
Countries in which APACMed has strong visibility and partnership will get the support to represent the industry to the respective regulatory. Regulators in the countries that are in the process of developing a sound regulatory structure also take feedback and suggestion from the association to understand the practises of other regions that could be vital in their process.